Cost-effectiveness of statins

This publication has 13 references indexed in Scilit:

• Direct Medical Costs of Coronary Artery Disease in the United States
  The American Journal of Cardiology, 1998
• Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia
  Atherosclerosis, 1997
• Task force 6. Cost effectiveness of assessment and management of risk factors
  Journal of the American College of Cardiology, 1996
• Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Discontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?
  New England Journal of Medicine, 1995
• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Cost-Effectiveness of Drug Therapy for Hypercholesterolaemia
  PharmacoEconomics, 1992
• A Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering Treatment
  International Journal of Technology Assessment in Health Care, 1992
• Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.
  American Journal of Public Health, 1987
• Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
  New England Journal of Medicine, 1977